Of Monsters and Men
By George Estreich, Biopolitical Times guest contributor
| 11. 29. 2012
To be interested in questions of human enhancement, while also being a sucker for Hollywood blockbusters about superheroes, makes for an odd movie experience. Immersed in a fictional world both saved and threatened by the enhanced, you’re aware of the world you’ve just paid to escape. You feel doubled, like the superheroes themselves—though since you’re sitting on the couch and not saving the world, the division is less profound. You don’t have secret powers, just cognitive dissonance; your perception, not your identity, is split.
A few nights ago, I watched The Amazing Spider-Man on Blu-Ray. (Warning: many spoilers ensue.) The movie reboots the franchise that began in 2002, and this time around, the genetic enhancement of human beings is far more central to the plot. Just as in the first series, the high school student Peter Parker, bitten by a genetically modified spider, develops superpowers; but this time around, the spider comes from a corporation whose business model depends on “cross-species genetics,” and Peter’s nemesis—the scientist Curtis Connors, once the research partner of Peter’s deceased father—is a man with one...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...